3BBLACKBIOHealthcare Service Provider
3B Blackbio Diagnostics Ltd — Cash Flow Statement
₹1126.00
-4.20%
3B Blackbio Diagnostics Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 42.45 Cr | 26.44 Cr | 18.26 Cr | 35.06 Cr | — |
| Repayment Of Debt | -0.54 Cr | -1.31 Cr | -0.57 Cr | -0.18 Cr | — |
| Issuance Of Capital Stock | 0.00 | 20000.00 | 0.00 | 3000.00 | — |
| Capital Expenditure | -0.90 Cr | -0.51 Cr | -2.02 Cr | -2.26 Cr | — |
| End Cash Position | 68.83 Cr | 62.15 Cr | 59.21 Cr | 28.89 Cr | — |
| Beginning Cash Position | 62.15 Cr | 59.21 Cr | 28.89 Cr | 35.08 Cr | — |
| Effect Of Exchange Rate Changes | 0.39 Cr | -0.07 Cr | 0.30 Cr | 0.00 | — |
| Changes In Cash | 6.29 Cr | 3.01 Cr | 30.01 Cr | -6.19 Cr | — |
| Financing Cash Flow | -3.22 Cr | -3.63 Cr | -5.01 Cr | -15.07 Cr | — |
| Interest Paid Cff | -0.11 Cr | -0.12 Cr | -0.20 Cr | -0.11 Cr | — |
| Cash Dividends Paid | -2.57 Cr | -2.19 Cr | -4.44 Cr | -15.46 Cr | — |
| Common Stock Dividend Paid | -2.57 Cr | -2.19 Cr | -4.44 Cr | -15.46 Cr | — |
| Net Common Stock Issuance | 0.00 | 20000.00 | 0.00 | 3000.00 | — |
| Common Stock Issuance | 0.00 | 20000.00 | 0.00 | 3000.00 | — |
| Net Issuance Payments Of Debt | -0.54 Cr | -1.31 Cr | -0.44 Cr | 0.53 Cr | — |
| Net Long Term Debt Issuance | -0.54 Cr | -1.31 Cr | -0.44 Cr | 0.53 Cr | — |
| Long Term Debt Payments | -0.54 Cr | -1.31 Cr | -0.57 Cr | -0.18 Cr | — |
| Investing Cash Flow | -33.85 Cr | -20.32 Cr | 14.73 Cr | -28.44 Cr | — |
| Net Other Investing Changes | -2000.00 | — | 0.05 Cr | 81000.00 | -0.05 Cr |
| Net Investment Purchase And Sale | -32.94 Cr | -19.81 Cr | 14.46 Cr | -33.83 Cr | — |
| Purchase Of Investment | -32.94 Cr | -19.81 Cr | — | -33.83 Cr | -68.53 Cr |
| Net PPE Purchase And Sale | -0.90 Cr | -0.51 Cr | -2.02 Cr | -2.26 Cr | — |
| Operating Cash Flow | 43.36 Cr | 26.95 Cr | 20.28 Cr | 37.33 Cr | — |
| Taxes Refund Paid | -14.78 Cr | -10.84 Cr | -8.94 Cr | -10.56 Cr | — |
| Change In Working Capital | -0.99 Cr | -1.59 Cr | -4.52 Cr | 3.89 Cr | — |
| Change In Payable | 1.12 Cr | 8.27 Cr | -2.14 Cr | -26.77 Cr | — |
| Change In Inventory | -0.31 Cr | -0.12 Cr | -0.61 Cr | -2.56 Cr | — |
| Change In Receivables | -1.80 Cr | -9.74 Cr | -1.77 Cr | 33.21 Cr | — |
| Other Non Cash Items | 0.11 Cr | -0.21 Cr | 0.20 Cr | 0.11 Cr | — |
| Depreciation And Amortization | 1.09 Cr | 1.06 Cr | 0.86 Cr | 0.67 Cr | — |
| Depreciation | 1.09 Cr | 1.06 Cr | 0.86 Cr | 0.67 Cr | — |
| Gain Loss On Investment Securities | -6.06 Cr | -5.79 Cr | -2.62 Cr | — | — |
| Gain Loss On Sale Of PPE | 0.00 | -0.01 Cr | 0.00 | 0.00 | — |
| Net Income From Continuing Operations | 64.00 Cr | 44.33 Cr | 35.31 Cr | 43.22 Cr | — |
| Net Other Financing Charges | — | -0.20 Cr | 0.07 Cr | -0.03 Cr | 0.18 Cr |
| Dividends Received Cfi | — | 0.00 | 2.25 Cr | 7.64 Cr | 0.00 |
| Sale Of Investment | — | 0.00 | 14.46 Cr | 0.00 | — |
| Issuance Of Debt | — | — | 0.07 Cr | 0.70 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | — | -1000.00 | — | — |
| Long Term Debt Issuance | — | — | 0.07 Cr | 0.70 Cr | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on 3B Blackbio Diagnostics Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.